Schrodinger ROE 2019-2025 | SDGR

Current and historical return on equity (ROE) values for Schrodinger (SDGR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Schrodinger ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.19B $0.37B -44.70%
2024-12-31 $-0.19B $0.42B -40.26%
2024-09-30 $-0.18B $0.45B -35.85%
2024-06-30 $-0.20B $0.47B -38.46%
2024-03-31 $-0.14B $0.51B -25.74%
2023-12-31 $0.04B $0.55B 6.91%
2023-09-30 $0.04B $0.56B 7.95%
2023-06-30 $0.07B $0.61B 12.50%
2023-03-31 $0.01B $0.59B 2.81%
2022-12-31 $-0.15B $0.45B -30.80%
2022-09-30 $-0.15B $0.46B -29.94%
2022-06-30 $-0.15B $0.49B -27.39%
2022-03-31 $-0.14B $0.53B -23.75%
2021-12-31 $-0.10B $0.56B -17.01%
2021-09-30 $-0.08B $0.58B -13.27%
2021-06-30 $-0.04B $0.61B -6.74%
2021-03-31 $-0.01B $0.63B -1.83%
2020-12-31 $-0.02B $0.62B -5.20%
2020-09-30 $-0.02B $0.63B -6.06%
2020-06-30 $-0.04B $0.30B -20.87%
2020-03-31 $-0.03B $0.30B -34.52%
2019-12-31 $-0.03B $0.10B -106.12%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.917B $0.208B
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.227B 59.07
Hims & Hers Health (HIMS) United States $12.367B 128.49
Tempus AI (TEM) United States $12.011B 0.00
IRhythm Technologies (IRTC) United States $4.742B 0.00
Inspire Medical Systems (INSP) United States $4.033B 63.01
Hinge Health (HNGE) United States $2.855B 0.00
Privia Health (PRVA) United States $2.804B 191.67
Enovis (ENOV) United States $1.916B 10.69
Phreesia (PHR) United States $1.667B 0.00
Clover Health Investments (CLOV) United States $1.522B 0.00
Omnicell (OMCL) United States $1.463B 25.82
Azenta (AZTA) United States $1.393B 64.72
10x Genomics (TXG) United States $1.311B 0.00
Fulgent Genetics (FLGT) United States $0.663B 0.00
Butterfly Network (BFLY) United States $0.645B 0.00
Claritev (CTEV) United States $0.631B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.372B 824.33
Outset Medical (OM) United States $0.366B 0.00
Health Catalyst (HCAT) United States $0.288B 0.00
Nyxoah SA (NYXH) Belgium $0.266B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.124B 0.00
American Well (AMWL) United States $0.115B 0.00
MDxHealth SA (MDXH) Belgium $0.102B 0.00
CareCloud (CCLD) United States $0.094B 3.60
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.030B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
Precipio (PRPO) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00